June 17, 2025CorporateTerumo and MedHub-AI partner to market AI-based FFR in Japan Aiming to provide a minimally invasive and time-efficient coronary physiology assessment through digital solutions
May 27, 2025CorporateTerumo Interventional Systems Announces Commercial Availability of Its ROADSAVER™ Carotid Stent System– Innovative, dual-layer micromesh, closed-cell stent with the flexibility of an open-cell stent for maximizing clinical outcomes in carotid artery stenting procedures –
May 14, 2025FinancialNotice concerning differences in non-consolidated financial results between FY2023 and FY2024 (PDF 108.74 KB)
Site Map Show — Site Map Hide — Site Map What’s new News Press Inquiries About Terumo Dear Stakeholders Group Mission Who We Are Corporate Governance Compliance Regulations and Standards Procurement Activity At a Glance Leadership Team History Brand Video "Our Promise" Terumo's Response to COVID-19 Education and Training Terumo Ventures Business Overview Terumo Interventional Systems Terumo Neuro Terumo Cardiovascular / HeartSheet Division Terumo Aortic Hospital Care Solutions Life Care Solutions Pharmaceutical Solutions Terumo Blood and Cell Technologies Company (Terumo Blood and Cell Technologies) Sustainability Sustainability News Sustainability at the Terumo Group GRI Standards Index Technology From Devices to Solutions Special Movies “Our Solutions” Terumo’s strengths—the 3Ds The Solutions Terumo Aims for Basic Information Research and Development Production and Supply Intellectual Property Investors Management Policy Management Policy Top Management Message Business Risks Disclaimer IR Policy IR Library Financial Statements Presentations Terumo Reports Terumo Report (online version) IR Events IR Inquiries Financial Highlights Shareholders & Stock Shareholders Meeting Stock Information Shareholder Return Credit Ratings and Corporate Bond Analyst Coverage Articles of Incorporation Site Quote Terms and Conditions of Use Privacy Policy Social Media Policy
Top
Top